Hematopoietic Stem Cell Transplantation (HSCT) Market Trend Analysis, Growth and Forecast 2025 

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Snapshot

The global market hematopoietic stem cell transplantation (HSCT) has been witnessing a high rise in its valuation and size over the last few years and is anticipated to remain doing so over the next few years. The considerable rise in the geriatric population and the increasing prevalence of non-communicable diseases is the key driving force behind the growth of this market. The increasing life expectancy, growing income, and the escalating government expenditure on health care, free trade agreement, and continuous research and development are other prominent factors, boosting the demand for HSCT across the world.

View Report @ http://www.transparencymarketresearch.com/hematopoietic-stem-cell-transplantation-market.html

Over the coming years, the worldwide HSCT market is expected to gain substantially from the continual research and development to provide innovative drugs and treatment for a host of diseases. In terms of opportunity, the market is estimated to increase at a CAGR of 12.80% from 2017 to 2025, rising from a value of US$13.06 bn in 2016 to US$37.61 bn by the end of 2025.

Europe to Continue Leading Global Hematopoietic Stem Cell Transplantation (HSCT) Market

On the basis of geography, the global hematopoietic stem cell transplantation market is classified into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Among these, Europe and North America have been leading the global market with a large population size, increase in health expenditure, and the presence of a state-of-art medical and healthcare infrastructure. Europe holds the dominant position in the global market and is anticipated to remain on the top over the next few years on account of the rising prevalence of hematological as well as non-hematological disorders.

The second position in the global HSCT market has been acquired by North America. The presence of a well-established medical and healthcare industry, increasing investments for research and development, introduction of improved and technologically advanced hematopoietic stem cells transplantation services on regular intervals, and the high gross domestic product (GDP) of countries in this region are some of the key factors behind the rise of the North America HSCT market.

Allogeneic Transplants to Dominate Global Market

Based on the type of transplant, the worldwide market for hematopoietic stem cell transplantation (HSCT) has been categorized into allogeneic transplants and autologous transplants. The allogeneic transplants segment has been leading this market and is expected to continue on the top over the next few years. Allogeneic transplants are of two types: Family related and unrelated transplant.

The increasing number of donors and post-transplant survival rates are likely to drive this segment in the years to come. The autologous segment, on the other hand, is anticipated to grow steadily over the forthcoming years on account of the usage of autologous transplants as the standard of care for multiple myeloma (MM) patients.

Regen Biopharma Inc., Escape Therapeutics Inc., Cryo-Save AG, Lonza Group Ltd., Pluristem Therapeutics Inc., China Cord Blood Corp., CBR Systems Inc., and ViaCord Inc. are the leading players operating in the global market for hematopoietic stem cell transplantation (HSCT).

Get accurate market forecast and analysis on the Hematopoietic Stem Cell Transplantation (HSCT) Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23861

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Europe to Continue Leading Global Hematopoietic Stem Cell Transplantation (HSCT) Market

On the basis of geography, the global hematopoietic stem cell transplantation market is classified into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Among these, Europe and North America have been leading the global market with a large population size, increase in health expenditure, and the presence of a state-of-art medical and healthcare infrastructure. Europe holds the dominant position in the global market and is anticipated to remain on the top over the next few years on account of the rising prevalence of hematological as well as non-hematological disorders.

The second position in the global HSCT market has been acquired by North America. The presence of a well-established medical and healthcare industry, increasing investments for research and development, introduction of improved and technologically advanced hematopoietic stem cells transplantation services on regular intervals, and the high gross domestic product (GDP) of countries in this region are some of the key factors behind the rise of the North America HSCT market.

Allogeneic Transplants to Dominate Global Market

Based on the type of transplant, the worldwide market for hematopoietic stem cell transplantation (HSCT) has been categorized into allogeneic transplants and autologous transplants. The allogeneic transplants segment has been leading this market and is expected to continue on the top over the next few years. Allogeneic transplants are of two types: Family related and unrelated transplant.

The increasing number of donors and post-transplant survival rates are likely to drive this segment in the years to come. The autologous segment, on the other hand, is anticipated to grow steadily over the forthcoming years on account of the usage of autologous transplants as the standard of care for multiple myeloma (MM) patients.

Regen Biopharma Inc., Escape Therapeutics Inc., Cryo-Save AG, Lonza Group Ltd., Pluristem Therapeutics Inc., China Cord Blood Corp., CBR Systems Inc., and ViaCord Inc. are the leading players operating in the global market for hematopoietic stem cell transplantation (HSCT).

Designed by CyFocus.com
Powered by CyFocus.net